FIELD: medicine.
SUBSTANCE: invention refers to method, and concerns a method for making a lyophilised antiviral agent consisting of dissolving a peptide in water, mixing the prepared solution with a number of structure-forming substances, sterilising and lyophilising including freezing out and drying. As a peptide, the peptide His-Gly-Val-Ser-Gly-Trp-Gly-Gln-His-Gly-Thr-His-Gly is used.
EFFECT: invention provides optimising the process enabling preparing the broad-spectrum lyophilised antiviral agent corresponding to the certified pharmacopeial description of the manufacturer.
3 cl, 1 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BIOLOGICALLY ACTIVE DERIVATIVES OF ALLOFERON-1 | 2013 |
|
RU2576830C2 |
| BIOLOGICALLY ACTIVE PEPTIDES | 2013 |
|
RU2575069C2 |
| INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
| COMPOSITION FOR OPTICAL VISUALIZATION, METHOD OF ITS PRODUCTION AND USE | 2019 |
|
RU2802481C2 |
| PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM | 2017 |
|
RU2678203C2 |
| STABLE FORMULATIONS OF ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 AND RELATED TREATMENT METHODS | 2012 |
|
RU2563346C2 |
| COMPOSITION FOR PREPARATION OF ANTI-TUMOR MEDICATION AND METHOD FOR PREPARATION OF ANTI-TUMOR MEDICATION BASED ON IT | 2016 |
|
RU2667128C2 |
| PHARMACEUTICAL COMPOSITION, CONTAINING N-ACYL DERIVATIVES OF AMINO ACIDS, AND THEIR APPLICATION AS ANTI-ALLERGIC, ANTI-ANAPHYLACTIC AND ANTI-INFLAMMATORY MEDICATIONS | 2008 |
|
RU2406727C2 |
| LYOPHILIZED PHARMACEUTICAL COMPOSITIONS FOR NAKED DNA GENE THERAPY | 2019 |
|
RU2795471C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODIES TO PCSK-9, AND ITS USE | 2018 |
|
RU2782792C2 |
